RPA’s announcements and analyses of federal regulations and legislative proposals with implications for nephrology practice are posted in this section.
Title |
Modified Date |
KCC PY 2025 Policy Updates | November 25, 2024 | Discussion Draft of the Medicare Patient Access and Practice Stabilization Act of 2024 | October 28, 2024 | October 11, 2024 Congressional Dear Colleague Letter on Physician Reimbursement | October 15, 2024 | RPA Summary and Analysis of the 2025 Medicare Fee Schedule Proposed Rule | July 17, 2024 | RPA Summary and Analysis of the 2023 Medicare Fee Schedule Final Rule | November 16, 2022 |
Optimal Care for Kidney Health MIPS Value Pathway (MVP) |
July 11, 2022 |
RPA Update on Split/Shared Services |
February 17, 2022 |
VBC CKD Guidance |
December 28, 2021 |
Acute Inpatient Dialysis Leadership Principles |
November 1, 2021 |
Rationale Maintaining the Quarterly Face to Face Requirement |
August 1, 2021 |
Summary of RPA 2020 Policy Successes
|
January 5, 2021 |
RPA Sign On Letter with Vascular Societies on NGS pAVF LCD
|
December 18, 2020 |
CMS Releases Final Rule for ESRD Treatment Choices (ETC) Payment Model
|
September 18, 2020 |
RPA Sign On Letter with the Transplant Roundtable on S. 3353, the Comprehensive Drug Coverage for Kidney Transplant Patients Act
|
September 3, 2020 |
RPA Sign-On Letter with NKF on Immunosuppressive Drug Coverage Legislation
|
August 31, 2020 |
RPA Issues Recommendations for Telehealth
|
August 10, 2020 |
RPA Preliminary Summary and Analysis of the 2021 Medicare Fee Schedule Proposed Rule
|
August 5, 2020 |
RPA Telehealth Survey: Summary Results
|
May 26, 2020 |
RPA Telehealth Survey: Detailed Results
|
May 26, 2020 |
RPA Sign On Letter with the Friends of NIDDK Calling for Increased NIDDK Funding
|
April 21, 2020 |
RPA Letter to Hospital Organizations and Insurers on Policies Limiting Emergent Care Provided to ESRD Patients
|
April 15, 2020 |
RPA/ASPN Letter to Congressional Leadership on COVID-19 Policy Revisions
|
March 23, 2020 |
RPA's Guidance on Billing and Coding for Remote Nephrology Services |
March 19, 2020 |
Kidney Community Letter to All House Offices supporting HR 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act |
January 7, 2020 |
Ways and Means Committee Surprise Billing Summary
|
|
RPA Guidance on Voluntary Payment Models
|
November 5, 2019 |
RPA Summary and Analysis of the 2020 Medicare Fee Schedule Final Rule
|
November 5, 2019 |
RPA Preliminary Summary and Analysis of CMS Request for Applications (RFA) for Voluntary Kidney Payment Models
|
October 25, 2019 |
Proposed Payment Rules Yield Positive Results for Nephrology |
July 29, 2019 |
CMS Status Update on PTAC Recommended APM Proposals |
January 4, 2019 |
|